WCM-Q Students Help Resolve Concern About Covid and Common Blood Pressure Medication.
Students at Weill Cornell Medicine-Qatar (WCM-Q) have helped answer a question about the potential dangers posed by blood pressure medication for those infected with COVID-19.
The trainee doctors all participated in a systematic review, which are used for evidence-based medicine and so may help healthcare professionals take medical decisions. The study examined whether a certain family of blood pressure-lowering medications (RAAS inhibitors) may upregulate the expression of ACE2, which is the protein that SARS-CoV-2 uses to invade our cells, and so increase the risk of infection or severity of the disease.
